Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Volitionrx Ltd as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −3 vs. Q2 2023
- Shares held
- 6.31M
- +22.9K (+0.4%) vs. Q2 2023
- Total value
- $4.35M
- −$4.39M (−50.3%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 6
- 8 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 3,882,850 | $2.68M | 1.76% | −46,260−1.2% | Reduced |
| BlackRock Inc. | 552,583 | $380.7K | 0.00% | −15,443−2.7% | Reduced |
| Vanguard Group Inc | 542,444 | $373.7K | 0.00% | +22,046+4.2% | Added |
| Geode Capital Management, LLC | 538,441 | $371.1K | 0.00% | +73,227+15.7% | Added |
| Morgan Stanley | 210,325 | $144.9K | 0.00% | −7,880−3.6% | Reduced |
| Bridgeway Capital Management, LLC | 176,100 | $121.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 123,923 | $85.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 89,546 | $61.7K | 0.00% | +19,454+27.8% | Added |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $38.3K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 28,151 | $19.4K | 0.00% | +12,262+77.2% | Added |
| Jane Street Group, LLC | 22,174 | $15.3K | 0.00% | +22,174 | New |
| Bank of New York Mellon Corp | 21,169 | $14.6K | 0.00% | −361−1.7% | Reduced |
| Charles Schwab Investment Management Inc | 15,384 | $10.6K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 10,624 | $7.32K | 0.01% | +10,624 | New |
| Sensible Money, LLC | 10,000 | $6.89K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,031 | $5.53K | 0.00% | −4,119−33.9% | Reduced |
| Hartford Financial Management Inc. | 5,000 | $3.44K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 4,000 | $2.76K | 0.00% | 00.0% | Unchanged |
| Founders Capital Management | 4,000 | $2.76K | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 2,500 | $1.72K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,876 | $1.29K | 0.00% | −9,031−82.8% | Reduced |
| National Bank of Canada | 1,000 | $741 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,000 | $689 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 439 | $302 | 0.00% | +125+39.8% | Added |
| Advisor Group Holdings, Inc. | 320 | $220 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 265 | $183 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 200 | $138 | 0.00% | −500−71.4% | Reduced |
| Allworth Financial LP | 200 | $138 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1 | $1 | 0.00% | −16,913−100.0% | Reduced |
| Qube Research & Technologies Ltd | 2 | $1 | 0.00% | +2 | New |
| DFPG Investments, LLC | 0 | $0 | 0.00% | −25,138−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −6,317−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,363−100.0% | Sold out |
| CarsonAllaria Wealth Management, Ltd. | 0 | $0 | 0.00% | −2,265−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −406−100.0% | Sold out |
| Adirondack Retirement Specialists, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Cowen Prime Advisors LLC | – | – | – | – | Not filed |